Page last updated: 2024-09-02

fingolimod hydrochloride and Diseases in Twins

fingolimod hydrochloride has been researched along with Diseases in Twins in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andabaka, M; Basile, MS; Cavalli, E; Drulovic, J; Fagone, P; Ivanovic, J; Kalfin, R; Mammana, S; Martinovic, V; Mazzon, E; Mesaros, S; Nicoletti, F; Pekmezovic, T; Pennisi, M; Petralia, MC	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Diseases in Twins

Article	Year
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod. Molecules (Basel, Switzerland), 2019, Dec-19, Volume: 25, Issue:1 Topics: Adult; Case-Control Studies; CD4-Positive T-Lymphocytes; Computer Simulation; Disease Progression; Diseases in Twins; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Interleukin-1; Male; Middle Aged; Multiple Sclerosis; Recurrence; Twins, Monozygotic; Up-Regulation	2019

Article

Year

In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod.

Molecules (Basel, Switzerland), 2019, Dec-19, Volume: 25, Issue:1

Topics: Adult; Case-Control Studies; CD4-Positive T-Lymphocytes; Computer Simulation; Disease Progression; Diseases in Twins; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Interleukin-1; Male; Middle Aged; Multiple Sclerosis; Recurrence; Twins, Monozygotic; Up-Regulation

2019